Gold is not always good enough: the shortcomings of randomization when evaluating interventions in small...

Area of Science:

• Clinical Trials Methodology
• Biostatistics
• Evidence-Based Medicine

Background:

• Valid inference in therapeutic intervention evaluation requires control, and minimizing both systematic and random error.
• Randomized controlled trials (RCTs) are the established gold standard for avoiding systematic error due to balanced covariate distribution.
• However, RCTs may not always achieve this, especially with small or heterogeneous patient samples.

Purpose of the Study:

• To evaluate the criteria for valid inference in therapeutic intervention studies.
• To assess the limitations of randomized controlled trials (RCTs) in specific contexts.
• To explore alternative strategies for ensuring valid inference in clinical research.

Main Methods:

• The study critically examines the principles of valid inference in clinical trials.
• It analyzes the strengths and limitations of randomization as a methodological tool.
• Alternative strategies like minimization are considered for achieving valid inference.

Main Results:

• Randomization's potential to avoid systematic error is not always realized in practice, particularly with small or heterogeneous patient samples.
• The rationale for randomization is undermined in circumstances where it fails to balance outcome determinants.
• Non-randomized strategies, such as minimization, offer potential for valid inference but face acceptance challenges.

Conclusions:

• Research design for intervention evaluation should be reconsidered for each study, prioritizing validity criteria.
• Focus should shift from methodological dogma (e.g., strict adherence to randomization) to achieving the core principles of valid inference.
• Minimization presents a viable alternative for valid inference when randomization is suboptimal.